The innovative clinical domain represents hybrid chains. Such synthetic molecules combine segments of multiple peptide origins, facilitating the creation of distinct biological functions. The strategy provides a https://chimerapeptides086022.uzblog.net/chimera-peptides-a-novel-therapeutic-frontier-57248289